Mundipharma names new president and chief executive officer
9 January 2018 -

Mundipharma, a Germany-based pharmaceutical company, has named Dr Alberto Martinez as its new president and chief executive officer, it was reported yesterday.

Martinez is to succeed Antony Mattessich, who leaves the network after 12 years of service to pursue his career in the United States.

In the new role, it is intended that Martinez will strengthen the company's network in Europe and focus on its alliances. He will also manage research and development, global manufacturing, supply chain and IT functions.

Dr Martinez joined the Mundipharma network in 2003 and has held roles of increasing responsibility over the past 14 years. Prior to his time at Mundipharma, he served Napp Pharmaceuticals and Janssen in various capacities.